Immunohistochemical detection of P504S in primary and metastatic renal cell carcinomas

Applied Immunohistochemistry and Molecular Morphology

Volumn 12, Issue 2, 2004, Pages 153-159

  Lin, Fan ^a   Brown, Robert E ^a   Shen, Ting ^b   Yang, Ximing J ^c   Schuerch, Conrad ^a  

^a GEISINGER MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

Colorectal adenocarcinoma; Metastatic renal cell carcinoma; P504S; Primary renal cell carcinoma

Indexed keywords

ALPHA METHYLACRYL COENZYME A RACEMASE; AVIDIN; BIOTIN; PEROXIDASE; PROTEIN P504S; RACEMASE; TUMOR MARKER; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CLEAR CELL CARCINOMA; COLORECTAL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; KIDNEY PROXIMAL TUBULE; LUNG ADENOCARCINOMA; METASTASIS; ONCOCYTOMA; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; STAINING; TUMOR DIFFERENTIATION;

EID: 2942720647     PISSN: 15412016     EISSN: None     Source Type: Journal    
DOI: 10.1097/00129039-200406000-00010     Document Type: Article

References (25)

1. Renshaw AA, Richie JP. Subtype of renal cell carcinoma: different onset and sites of metastatic disease. Am J Clin Pathol. 1999;111:539-43.
2. Zolota V, Tsamandas AC, Melachrinou M, et al. Expression of CD44 protein in renal cell carcinoma: association with p53 expression. Urol Oncol. 2002;7:13-7.
3. Avery AK, Beckstead J, Renshaw AA, et al. Use of antibody to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol. 2000;24:203-10.
4. Chu P, Arber DA. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms: frequent expression in renal cell carcinoma and endometrial stromal sarcoma. Am J Clin Pathol. 2000;113:374-82.
5. McGregor DK, Khurana KK, Cao C, et al. Diagnosing primary and metastatic renal cell carcinoma-the use of the monoclonal antibody "renal cell carcinoma marker." Am J Surg Pathol. 2001;25:1485-92.
6. Yoshida S, Imam A. Monoclonal antibody to a proximal nephrogenic renal antigen: immunohistochemical analysis of formalin-fixed, paraffin-embedded human renal cell carcinomas. Cancer Res. 1989;49:1802-9.
7. Liao SY, Aurelio ON, Jan K, et al. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res. 1997;57:2827-31.
8. Kuroda A, Inodu K, Guo L, et al. Expression of CD9/mobility-related protein 1 (MRP-1) in renal parenchymal neoplasms: consistent expression in papillary and chromophobe renal cell carcinomas. Hum Pathol. 2001;32:1071-7.
9. Tickoo S, Amin M, Linden MD, et al. Antimitochondrial antibody (113-1) in the differential diagnosis of granular renal cell tumors. Am J Surg. 1997;21:922-30.
10. Taki A, Nakatani Y, Misugi K, et al. Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases. Mod Pathol. 1999;12:310-7.
11. Khoury JD, Abrahams NA, Levin HS, et al. The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann Diagn Pathol. 2002;6:154-8.
12. Young AN, de Oliveira Salles PG, Lim SD, et al. Beta defensin-1, parvalbumin, and vimentin-a panel of diagnostic immunohistochemical markers for renal tumors derived from gene expression profiling studies using cDNA microarrays. Am J Surg Pathol. 2003;27:199-205.
13. Kuroda N, Naruse K, Miyazaki E, et al. Vinculin: its possible use as a marker of normal collecting ducts and renal neoplasms with collecting duct system phenotype. Mod Pathol. 2000;13:1109-14.
14. Sakai N, Baba M, Nagasima Y, et al. SPARC expression in primary human renal cell carcinoma: upregulation of SPARC in sarcomatoid renal carcinoma. Hum Pathol. 2001;32:1064-70.
15. Kim MK, Kim S. Immunohistochemical profile of common epithelial neoplasms arising in the kidney. Appl Immunohistochem Mol Morphol. 2002;10:332-8.
16. Xu J, Stolk JA, Zhang Z, et al. Identification of differentially expressed genes in human prostate cancer using subtraction and microarray. Cancer Res. 2000;60:1677-82.
17. Jiang Z, Woda BA, Rock KL, et al. P504S: a new molecular marker for detection of prostate carcinoma. Am J Surg Pathol. 2001;25:1379-404.
18. Jiang Z, Wu CL, Woda BA, et al. P504S/a-methylacryl CoA racemase, a useful marker for diagnosis of small foci of prostatic carcinoma on needle biopsy. Am J Surg Pathol. 2002;26:1169-74.
19. Jiang Z, Woda BA, Fanger G, et al. Expression of P504S in variant malignant neoplasms and normal tissues, a study of 715 cases. Mod Pathol. 2002;306A:1270.
20. Ferdinadusse S, Denis S, et al. Subcellular localization and physiological role of alpha-methylacryl-CoA racemase. J Lipid Res. 2000;41:1890-6.
21. Beach R, Gown AM, de Peralta-Venturina MN, et al. P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol. 2002;26:1588-96.
22. Yang XM, Wu CL, Woda BA, et al. Expression of a-methylacyl CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol. 2002;26:921-5.
23. Tretiakova M, Turkyilmaz M, Chekmareva M, et al. Immunophenotyping of renal cell neoplasms using a tissue microarray. Mod Pathol. 2002;184A:767.
24. Barbareschi M, Murer B, Colby TV, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol. 2003;27:141-9.
25. Werling RW, Yaziji H, Bacchi C, et al. CDX-2, a highly sensitive and specific marker of adenocarcinoma of intestinal origin. Am J Surg Pathol. 2003;27:303-10.